
Ken Kato, MD, PhD, National Cancer Center Hospital East
Advertisement
Articles by Ken Kato, MD, PhD, National Cancer Center Hospital East
















Advertisement
Latest Updated Articles
ESMO 2020: Practice-Changing Data in Esophageal CancerOctober 22nd 2020
First-Line I/O Successful in Gastric AdenocarcinomaOctober 22nd 2020
Predicting Response With Biomarkers in Gastric CancersOctober 22nd 2020
Optimal Approach Toward Advanced Gastric Cancers in USOctober 22nd 2020
Treatment Landscape in Gastric Cancers Pre-ESMO 2020October 22nd 2020
Applying New Data in the Real-World for GEJ CancerOctober 22nd 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma
2
FDA Accepts sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis
3
Beyond the Target: Payloads, Therapeutic Windows, and Biomarkers Shape the Next Wave of ADCs in NSCLC
4
Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC
5
